Bioanalytical Systems (BASI) Receiving Somewhat Favorable Press Coverage, Analysis Shows
Media stories about Bioanalytical Systems (NASDAQ:BASI) have trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bioanalytical Systems earned a media sentiment score of 0.23 on Accern’s scale. Accern also gave media headlines about the company an impact score of 44.5945420936417 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Shares of Bioanalytical Systems (NASDAQ:BASI) opened at $2.81 on Monday. Bioanalytical Systems has a twelve month low of $0.65 and a twelve month high of $2.90. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.51 and a current ratio of 0.64.
COPYRIGHT VIOLATION WARNING: This news story was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/bioanalytical-systems-basi-receiving-somewhat-favorable-press-coverage-analysis-shows/1757266.html.
Bioanalytical Systems Company Profile
Bioanalytical systems, Inc is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies.
Receive News & Ratings for Bioanalytical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.